Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder

Neuropsychopharmacology

Volumn 33, Issue 4, 2008, Pages 933-945

  Eastwood, Sharon L ^a,b   Harrison, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

Gene expression; Hippocampus; In situ hybridization; Isoform; Netrin G1; Netrin G2; Splice variant; Temporal cortex

Indexed keywords

CLOZAPINE; HALOPERIDOL; MEMBRANE ENZYME; MESSENGER RNA; NETRIN G1; NETRIN G2; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN CORTEX; BRAIN DEVELOPMENT; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GENETIC VARIABILITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; TEMPORAL LOBE;

ADULT; ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; EMBRYO, MAMMALIAN; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; RADIOGRAPHY; RATS; RNA, MESSENGER; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 39149105611     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301457     Document Type: Article

References (64)

1. Andreasen NC (1999). A unitary model of schizophrenia: Bleuler's 'fragmented phrene' as schizencephaly. Arch Gen Psychiatry 56: 781-787.
2. Aoki-Suzuki M, Yamada K, Meerabux J, Iwayama-Shigeno Y, Ohba H, Iwamoto K et al (2005). A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol Psychiatry 57: 382-393.
3. Arnold SE (2000). Cellular and molecular neuropathology of the parahippocampal region in schizophrenia. Ann NY Acad Sci 911: 275-292.
4. Barton AJL, Najlerahim A, Pearson RCA, Harrison PJ (1993). Pre-and postmortem influences on brain RNA. J Neurochem 61: 1-11.
5. Biederer T (2006). Hooking up new synapses. Nat Neurosci 9: 1203-1204.
6. Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R et al (2006). Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 11: 252-260.
7. Chih B, Engelman H, Scheiffele P (2005). Control of excitatory and inhibitory synapse formation by neuroligins. Science 307: 1324-1328.
8. Clancy B, Darlington RB, Finlay BL (2001). Translating developmental time across mammalian species. Neuroscience 105: 7-17.
9. Dean C, Dresbach T (2006). Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci 29: 21-29.
10. Duvernoy HM (1998). The Human Hippocampus. Functional Anatomy, Vascularization and Serial Sections with MRI, 2nd edn. Springer: Berlin.
11. Eastwood SL, Burnet PW, Harrison PJ (2000). Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain. Synapse 36: 167-177.
12. Eastwood SL, Cotter D, Harrison PJ (2001). Cerebellar synaptic protein expression in schizophrenia. Neuroscience 105: 219-229.
13. Eastwood SL, Harrison PJ (2000). Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5: 425-432.
14. Eastwood SL, Harrison PJ (2005). Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73: 159-172.
15. Eastwood SL, Salih T, Harrison PJ (2005). Differential expression of calcineurin A subunit mRNA isoforms during rat hippocampal and cerebellar development. Eur J Neurosci 22: 3017-3024.
16. Faraone SV, Lasky-Su J, Glatt SJ, Van EP, Tsuang MT (2006). Early onset bipolar disorder: possible linkage to chromosome 9q34. Bipolar Disord 8: 144-151.
17. Fatemi SH, Earle JA, Stary JM, Lee S, Sedgewick J (2001). Altered levels of the synaptosomal associated protein SNAP-25 in hipoocampus of subjects with mood disorders and schizophrenia. Neuroreport 12: 3257-3262.
18. Frankle WG, Lerma J, Laruelle M (2003). The synaptic hypothesis of schizophrenia. Neuron 39: 205-216.
19. Fukasawa M, Aoki M, Yamada K, Iwayama-Shigeno Y, Takao H, Meerabux J et al (2004). Case-control association study of human netrin G1 gene in Japanese schizophrenia. J Med Dent Sci 51: 121-128.
20. Garner CC, Nash J, Huganir RL (2000). PDZ domains in synapse assembly and signalling. Trends Cell Biol 10: 274-280.
21. Harrison PJ (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122: 593-624.
22. Harrison PJ (2002). The neuropathology of primary mood disorder. Brain 125: 1428-1449.
23. Harrison PJ (2004). The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174: 151-162.
24. Harrison PJ, Eastwood SL (1998). Preferential involvement of excitatory neurons in the medial temporal lobe in schizophrenia. Lancet 352: 1669-1673.
25. Harrison PJ, Eastwood SL (2001). Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11: 508-519.
26. Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA (1995). The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 200: 151-154.
27. Harrison PJ, Law AJ, Eastwood SL (2003). Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann NY Acad Sci 1003: 94-101.
28. Harrison PJ, Owen MJ (2003). Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361: 417-419.
29. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68.
30. Heckers S, Stone D, Walsh J, Shick J, Koul P, Benes F (2002). Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch Gen Psychiatry 59: 521-529.
31. Honer WG, Young CE (2004). Presynaptic proteins and schizophrenia. Int Rev Neurobiol 59: 1751-1799.
32. Honer WG, Young C, Falkai P (2000). Synaptic pathology. In: Harrison PJ, Roberts GW (eds). The Neuropathology of Schizophrenia. Progress and Interpretation. Oxford University Press: Oxford. pp 105-136.
33. Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E et al (2005). Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 33: e56.
34. Insausti R, Amaral D (2004). Hippocampal formation. In: Paxinos G, Mai G (eds). The Human Nervous System, 2nd edn. Academic: San Diego. pp 871-914.
35. Kim E, Sheng M (2004). PDZ domain proteins of synapses. Nat Rev Neurosci 5: 771-781.
36. Kim S, Burette A, Chung HS, Kwon SK, Woo J, Lee HW.et al (2006). NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nat Neurosci 9: 1294-1301.
37. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF, Stanley Neuropathology Consortium (2004). Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9: 609-620.
38. Law AJ, Deakin JF (2001). Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in psychoses. Neuroreport 12: 2971-2974.
39. Law AJ, Hutchinson LJ, Burnet PWJ, Harrison PJ (2004). Antipsychotics increase microtubule-associated protein 2 mRNA but not spinophilin mRNA in rat hippocampus and cortex. J Neurosci Res 76: 376-382.
40. Lewis DA, Levitt P (2002). Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25: 409-432.
41. Lewis DA, Hashimoto T, Volk DW (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6: 312-324.
42. Lin JC, Ho WH, Gurney A, Rosenthal A (2003). The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons. Nat Neurosci 6: 1270-1276.
43. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al (2006). Critical factors in gene expression in postmortem human brain: focus in studies in schizophrenia. Biol Psychiatry 60: 650-658.
44. Lise MF, El-Husseini A (2006). The neuroligin and neurexin families: from structure to function at the synapse. Cell Mol Life Sci 63: 1833-1849.
45. Nakashiba T, Ikeda T, Nishimura S, Tashiro K, Honjo T, Culotti JG et al (2000). Netrin-G1: a novel glycosyl phosphatidylinositol-linked mammalian netrin that is functionally divergent from classical netrins. J Neurosci 20: 6540-6550.
46. Nakashiba T, Nishimura S, Ikeda T, Itohara S (2002). Complementary expression and neurite outgrowth activity of netrin-G subfamily members. Mech Dev 111: 47-60.
47. Marenco S, Weinberger DR (2000). The neurodevelopmental hypothesis of schizophrenia: following a trail from the cradle to the grave. Dev Psychopathol 12: 501-527.
48. McCullumsmith RE, Kristiansen LV, Beneyto M, Scarr E, Dean B, Meador-Woodruff JH (2007). Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res 1127: 108-118.
49. McGlashan TH, Hoffman RE (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57: 637-648.
50. Meerabux JM, Ohba H, Fukasawa M, Suto Y, Aoki-Suzuki M, Nakashiba T et al (2005). Human netrin-G1 isoforms show evidence of differential expression. Genomics 86: 112-116.
51. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001). Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci 24: 479-486.
52. Mitsui K, Nakajima D, Ohara O, Nakayama M (2002). Mammalian fat3: a large protein that contains multiple cadherin and EGF-like motifs. Biochem Biophys Res Commun 290: 1260-1266.
53. Miyashita T, Nishimura-Akiyoshi S, Itohara S, Rockland KS (2005). Strong expression of NETRIN-G2 in the monkey claustrum. Neuroscience 136: 487-496.
54. Moises HW, Zoega T, Gottesman II (2002). The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia. BMC Psychiatry 2: 8.
55. Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ et al (2005). Hippocampal complexin proteins and cognitive dysfunction in schizophrenia. Arch Gen Psychiatry 62: 263-272.
56. Scarr E, Pavey G, Sundram S, MacKinnon A, Dean B (2003). Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord 5: 257-264.
57. Stan AD, Ghose S, Gao X-M, Roberts RC, Lewis-Amezcua K, Hatanpaa KJ et al (2006). Human post-mortem tissue: what quality markers matter? Brain Res 1123: 1-11.
58. Stephan KE, Baldeweg T, Friston KJ (2006). Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 59: 929-939.
59. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB (2005). Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 57: 252-260.
60. Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Missler M, Gottmann K et al (2006). Neuroligins determine synapse maturation and function. Neuron 51: 741-754.
61. Vawter MP, Freed WJ, Kleinman JE (2000). Neuropathology of bipolar disorder. Biol Psychiatry 48: 486-504.
62. Vawter MP, Thatcher L, Usen N, Hyde TM, Kleinman JE, Freed WJ (2002). Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol Psychiatry 7: 571-578.
63. Venken T, Claes S, Sluijs S, Paterson AD, Van DC, Adolfsson R et al (2005). Genomewide scan for affective disorder susceptibility Loci in families of a northern Swedish isolated population. Am J Hum Genet 76: 237-248.
64. Yin Y, Miner JH, Sanes JR (2002). Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. Mol Cell Neurosci 19: 344-358.